menu
    • menu

    Company profile for Repare Therapeutics

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Repare Therapeutics is a leading precision oncology company enabled by our proprietary synthetic lethality approach to discovering and developing novel therapeutics. We use our genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Repare TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    7210 Frederick-Banting, Suite 100, St-Laurent, Quebec, H4S 2A1
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.reparerx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gilead Sciences Acquires RP-3467, Pol-ATPase Inhibitor RP 3467
    Gilead Sciences Acquires RP-3467, Pol-ATPase Inhibitor RP 3467

    24 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251224800886/en/Repare-Therapeutics-Announces-Acquisition-of-Pol-ATPase-Inhibitor-RP-3467-by-Gilead-Sciences-for-Up-To-%2430-Million-in-Total-Consideration

    BUSINESSWIRE
    24 Dec 2025
    Share Share
    Repare Pharma Secures Backing From Major Shareholders
    Repare Pharma Secures Backing From Major Shareholders

    20 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251120902912/en/Repare-Therapeutics-Enters-into-Support-and-Voting-Agreements-with-Significant-Shareholders-for-Proposed-Transaction-with-XenoTherapeutics-Inc.

    BUSINESSWIRE
    20 Nov 2025
    Share Share
    Repare Nails Down Xenotherapeutics Buyout
    Repare Nails Down Xenotherapeutics Buyout

    17 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/repare-finds-fix-biotech-agrees-xenotherapeutics-buyout

    FIERCE BIOTECH
    17 Nov 2025
    Share Share
    Repare To Unveil Phase 1 LIONS Trial Data at AACR-NCI-EORTC
    Repare To Unveil Phase 1 LIONS Trial Data at AACR-NCI-EORTC

    13 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251013080571/en/Repare-Therapeutics-to-Present-Initial-Data-from-Phase-1-LIONS-Clinical-Trial-at-37th-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics

    BUSINESSWIRE
    13 Oct 2025
    Share Share
    Repare Therapeutics Reports Q2 2025 Financial Results and Updates
    Repare Therapeutics Reports Q2 2025 Financial Results and Updates

    08 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250808848117/en/Repare-Therapeutics-Provides-Business-Update-and-Reports-Second-Quarter-2025-Financial-Results

    BUSINESSWIRE
    08 Aug 2025
    Share Share
    Repare Partners with Debiopharm for PKMYT1 Inhibitor
    Repare Partners with Debiopharm for PKMYT1 Inhibitor

    16 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/repare-finds-suitor-paused-pkmyt1-inhibitor-current-partner-debiopharm

    FIERCE BIOTECH
    16 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search